APA (7th ed.) Citation

Bochtler, T., Hegenbart, U., Seckinger, A., Dietrich, S., Granzow, M., Neben, K., . . . Schönland, S. (2014). Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone. Amyloid, 21(1), . https://doi.org/10.3109/13506129.2013.854766

Chicago Style (17th ed.) Citation

Bochtler, Tilmann, et al. "Gain of Chromosome 1q21 Is an Independent Adverse Prognostic Factor in Light Chain Amyloidosis Patients Treated with Melphalan/dexamethasone." Amyloid 21, no. 1 (2014). https://doi.org/10.3109/13506129.2013.854766.

MLA (9th ed.) Citation

Bochtler, Tilmann, et al. "Gain of Chromosome 1q21 Is an Independent Adverse Prognostic Factor in Light Chain Amyloidosis Patients Treated with Melphalan/dexamethasone." Amyloid, vol. 21, no. 1, 2014, https://doi.org/10.3109/13506129.2013.854766.